Every recall we track for SCA Pharmaceuticals, LLC — 57 in all — plus the complaints and injury reports the public filed about them.
SCA Pharmaceuticals recalls fentanyl injection products due to lack of sterility assurance. This may cause infections if used improperly. Consumers should contact the manufacturer for details.
SCA Pharmaceuticals recalls fentanyl injections due to lack of sterility assurance. This could lead to infections if used improperly. Affected lots expire by November 2023.
SCA Pharmaceuticals recalls phenylephrine HCl 500 mcg/5 mL injections due to lack of sterility assurance. This could lead to infections if used improperly. Consumers should check product details and contact the manufacturer for instructions.
SCA Pharmaceuticals recalls specific lots of 200 mg/10mL Succinylcholine Chloride injections due to lack of sterility assurance. This could lead to infections if used improperly. Affected products have unique lot numbers and expiration dates.
SCA Pharmaceuticals recalls hydro morphine injections with potential lack of sterility. Affected products include specific lot numbers and expiration dates. Consumers should check their product details and contact the manufacturer for guidance.
SCA Pharmaceuticals recalls 250mL Vancomycin injections due to lack of sterility assurance. Affected lots expire Dec 2023. No remedy specified in official notice.
SCA Pharmaceuticals recalls hydrocodone injections with potential lack of sterility. Affected products include specific lot numbers and expiration dates. Consumers should check their product details and contact the manufacturer for guidance.
SCA Pharmaceuticals recalls fentanyl 500 mcg/100mL injections due to lack of sterility assurance. This affects specific lots manufactured between 2022-2023. Patients should contact their healthcare provider for guidance.
SCA Pharmaceuticals recalls phenylephrine injections with potential lack of sterility. Affected lots expire by 2024; consumers should contact the manufacturer for details.
SCA Pharmaceuticals recalls 125mg Diltiazem HCl injection due to lack of sterility assurance. This prescription-only product (NDC 70004-0541-35) may pose infection risks if used.
SCA Pharmaceuticals recalls specific lots of Midazolam HCl 100 mg/100 mL injection (Rx only) due to lack of sterility assurance. This could lead to infections if used improperly. Check your product details to see if you have affected lots.
SCA Pharmaceuticals recalls hydro morphine injection (NDC 70004-0303-17) due to lack of sterility assurance. This may cause infections if used improperly.
SCA Pharmaceuticals recalls phenylephrine HCl 800 mcg/10mL injection with potential lack of sterility. Affected lots expire April 2024. Consumers should contact the manufacturer for details.
SCA Pharmaceuticals recalls fentanyl injections due to lack of sterility assurance. This affects specific lots manufactured in 2023. Consumers should contact the manufacturer for details.
SCA Pharmaceuticals recalls specific Hydro Morphone HCl syringes due to lack of sterility assurance. Affected lots expire by November 2023. Consumers should contact the manufacturer for details.
SCA Pharma recalls neostigmine methylsulfate 5 mg/5 mL injection with potential lack of sterility. This prescription drug may pose infection risks if used.
SCA Pharmaceuticals recalls fentanyl injections due to lack of sterility assurance. This could lead to infections if used improperly. Contact the manufacturer for details.
SCA Pharmaceuticals recalls sterile SUCcinylcholine Chloride 100 mg/5mL injection due to lack of assurance of sterility. Affected lots expire by November 2023.
SCA Pharmaceuticals recalls PHENYLephrine HCl 400 mcg/10mL injections due to lack of sterility assurance. This may cause infections if used improperly. Affected lots have specific expiration dates.
SCA Pharmaceuticals recalls hydro morphine injections with lack of sterility assurance. Affected lots expire by December 2023. Consumers should contact the manufacturer for details.
SCA Pharmaceuticals recalls fentanyl injections with potential lack of sterility. Affected lots expire by December 2023 or January 2024. Consumers should contact the manufacturer for details.
SCA Pharmaceuticals recalls fentanyl injections with potential lack of sterility. This could cause infections if used improperly. Check your product details and contact the company for action steps.
SCA Pharmaceuticals recalls phenylephrine HCl 40mg injection (NDC 70004-0825-40) due to lack of sterility assurance. This product may cause infections if used.
SCA Pharmaceuticals recalls hydro morphine injection (NDC 70004-0303-21) due to lack of sterility assurance. Products may cause infection if used improperly. Contact for return instructions.
SCA Pharmaceuticals recalls labetalol HCl 20mg/4mL injection (NDC 70004-0700-28) due to lack of sterility assurance. This medication is prescription-only and may pose infection risks if used.
SCA Pharmaceuticals recalls specific lots of phenylephrine HCl injection (5000 mcg/50mL) due to lack of sterility assurance. This could lead to infections if used improperly. Consumers should check lot numbers and contact the manufacturer for details.